Senomyx Inc.  

(Public, NASDAQ:SNMX)   Watch this stock  
Find more results for Mary E. Herman
8.85
+0.69 (8.46%)
Apr 16 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.17 - 9.04
52 week 1.81 - 12.74
Open 8.22
Vol / Avg. 0.00/916,131.00
Mkt cap 368.51M
P/E     -
Div/yield     -
EPS -0.29
Shares 41.64M
Beta 1.37
Inst. own 54%
Apr 21, 2014
Q1 2014 Senomyx, Inc. Earnings Release (Estimated) Add to calendar
Apr 9, 2014
Senomyx, Inc. at Needham Healthcare Conference - Webcast
Mar 13, 2014
Q4 and Year-End 2013 Senomyx, Inc. Earnings Conference Call - Webcast
Mar 13, 2014
Q4 2013 Senomyx, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -41.65% -40.63%
Operating margin -41.75% -40.75%
EBITD margin - -31.02%
Return on average assets -28.93% -25.08%
Return on average equity -61.43% -52.41%
Employees 113 -
CDP Score - -

Address

4767 Nexus Centre Drive
SAN DIEGO, CA 92121
United States - Map
+1-858-6468300 (Phone)
+1-858-4040752 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Senomyx, Inc. is focused on using taste receptor technologies to discover and develop flavor ingredients for the packaged food, beverage and ingredient supply industries. These flavor ingredients include flavors, such as savory flavors and cooling flavors; and flavor modulators, such as sweet and salt enhancers, and bitter blockers. The Company has collaborative agreements with several of the packaged food, beverage and ingredient companies, including Ajinomoto Co., Inc., Firmenich SA, Nestle SA, and PepsiCo, Inc. The Company has developed taste receptor-based assays for use in its screening systems and to screen its compound libraries and identify potential flavor ingredients. The Company is developing flavor ingredients to enable its collaborators to reduce the levels of sugar, artificial sweeteners, salt and monosodium glutamate (MSG) in packaged food and beverage products.

Officers and directors

Kent Snyder Chairman of the Board
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John W. Poyhonen President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Antony E. Rogers Chief Financial Officer, Senior Vice President
Age: 46
Bio & Compensation  - Reuters
Donald S. Karanewsky Ph.D. Senior Vice President, Chief Scientific Officer
Age: 61
Bio & Compensation  - Reuters
Sharon Wicker Senior Vice President, Chief Commercial Development Officer
Age: 57
Bio & Compensation  - Reuters
Jay M. Short Ph.D. Lead Independent Director
Age: 55
Bio & Compensation  - Reuters
Roger D. Billingsley Ph.D. Independent Director
Age: 61
Bio & Compensation  - Reuters
Stephen A. Block Esq. Independent Director
Age: 68
Bio & Compensation  - Reuters
Mary Ann Gray Ph.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Michael E. Herman Independent Director
Bio & Compensation  - Reuters